HSP90AB1 and malignant pleural mesothelioma: In highly chemo-resistant malignant pleural mesothelioma, the chaperone protein HSP90 plays an important role in assisting the chemotherapy-induced senescence-associated secretory phenotype, and inhibition of HSP90 can modulate chemotherapy sensitivity by reducing IL-8 levels [42].